摘要
目的观察血管紧张素酶抑制剂(ACEI)—福辛普利(FOS)对脂多糖(LPS)诱导大鼠肾小球系膜细胞(GMC)转化生长因子-β(TGF-β1)蛋白及mRNA表达的影响,探讨FOS延缓肾小球硬化机制。方法按经典方法体外培养大鼠GMC,转种培养后分为对照组、LPS组、LPS+FOS组。采用ELISA法测定GMC培养上清6、12、24 h TGF-β1蛋白水平,荧光半定量RT-PCR法检测TGF-β1mRNA表达。结果LPS诱导组GMC分泌TGF-β1蛋白及mRNA表达均高于对照组,LPS+FOS组GMC分泌TGF-β1及mR-NA表达较LPS组明显下降。结论FOS从蛋白和mRNA两个水平均对体外培养大鼠GMC产生TGF-β1有明显抑制作用,提示FOS抑制GMC产生TGF-β1可能是延缓肾小球硬化的重要作用机制之一。
Objective To observe the effects of fosinopril (FOS), a new generation angiotensin- converting enzyme inhibitor (ACEI) ,on protein and mRNA expression of transforming growth factor-β1 (TGF-β1) of rat glomerular mesangial cell(GMC) induced by lipopolysaccharide(LPS) ; to demonstrate the preventive mechanism against glomerular sclerosis by applying FOS. Methods The cultured GMC in classic way were divided into 3 groups: control group; LPS group; LPS + FOS group. TGF-β1 concentration in GMC superrlatant fluid was detected by ELISA; TGF-β1 mRNA expression was determined by semiquantitative real- time RT- PCR. Results LPS group was obviously higher than control groups in TGF-β1 secretion and mRNA expression, while LPS + FOS group decreased distinctively in TGF-β1 secretion and mRNA expression compared with LPS group. Conclusions FOS has obviously inhibited on TGF-β1 expression of rat GMC both at protein level and mRNA level, which reveals that it may be an important mechanism by FOS on restraining the development of glomerulosclerosis.
出处
《实用儿科临床杂志》
CAS
CSCD
北大核心
2006年第13期841-842,844,共3页
Journal of Applied Clinical Pediatrics
基金
广东省医学科研基金项目资助(2002561)